The median serum SOD1 and SOD2 concentrations were significantly higher in lung cancer patients compared to control subjects (218.9 vs. 141.0 pg/mL, and 1.30 vs. 0.78 ng/mL, respectively). The gene discussed is SOD1; the disease is lung cancer.